Home » Topics » BioWorld Science

BioWorld Science
RSS

Tyrosine kinase inhibitor NTRC-0652-0 shows promise for the treatment of cholangiocarcinoma

Feb. 3, 2022

Discovery of novel ATX inhibitor with promising antifibrosis efficacy in rodents

Feb. 2, 2022

Neuronal PFKFB3 upregulation involved in ceroid lipofuscinosis

Feb. 2, 2022

Skye reports data on SBI-100 ophthalmic nanoemulsion in preclinical glaucoma model

Feb. 2, 2022

Catalog of protein isoforms in blood cells can predict organ rejection

Feb. 2, 2022

Sarepta and GenEdit report progress under collaboration for neuromuscular diseases

Feb. 2, 2022

CCR4 mediates postoperative pain through skin dendritic cells

Feb. 2, 2022

HMGB1 restricts EPO signaling, contributing to anemia of inflammation

Feb. 2, 2022

SLAMF3 and SLAMF4 targeting for treating hematopoietic cancers

Feb. 2, 2022

Beijing Findcure Biosciences divulges new tyrosine-protein kinase receptor UFO inhibitors

Feb. 2, 2022

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...